![]() Reducing therapy to one treatment session also would open up much more time for proton centers so many more patients could be treated. If this and other trials show benefit and improved outcomes from FLASH, it is possible this may become the primary treatment method for many cancers in the years to come. Lab testing has shown this actually has a healthy tissue sparing capability and may help in reducing collateral damage. The premise of FLASH is to deliver extremely high doses of radiation to a tumor in one, short dose. This study is testing the use of a single FLASH proton therapy session, rather than weeks of fractionated doses.įLASH and hypo fractionated therapy have been among the hottest topics in radiation oncology. ![]() Breneman, M.D., medical director of the Cincinnati Children's/ UC Health Proton Therapy Center, and the principal investigator of the FAST-01 trial, explains FLASH therapy and details on the trial. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |